BioCentury
ARTICLE | Clinical News

Depo-subQ provera 104 regulatory update

April 11, 2005 7:00 AM UTC

FDA approved an NDA for Depo-subQ provera 104 medroxyprogesterone acetate injectable suspension to treat pain caused by endometriosis. ...